Dry adsorbed emulsion:: 2.: Dissolution behaviour of an intricate formulation

被引:15
作者
Chambin, O [1 ]
Bérard, V [1 ]
Rochat-Gonthier, MH [1 ]
Pourcelot, Y [1 ]
机构
[1] Univ Bourgogne, UFR Pharm, Grp Technol Poudres Usage Pharmaceut, F-21079 Dijon, France
关键词
dry emulsion; dissolution; particle; sustained release;
D O I
10.1016/S0378-5173(01)00991-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The behaviour of a pharmaceutical form, called dry adsorbed emulsion (DAE). containing a sparingly soluble drug (i.e. theophylline) was studied for dissolution drug release kinetic, in relation with DAE structure characterisation. In vitro dissolution testings were performed under different experimental conditions (medium at pH 1.2 and 7.4, medium with or without surfactant addition, different particle sizes, discrete or densified particles). Discrete DAE particles showed an extended release, in comparison with the native drug powder, depending on both drug Solubility in the medium and particle size. The relevance of dissolution data was not improved by surfactant addition (0.1% sodium lauryl sulfate: SLS). After an initial release due to theophylline of the DAE superficial layer, the dissolution followed the Higuchi model. This suggested that DAE behaved as an inert matrix, which controlled drug release by diffusion through the hydrophobic part of the DAE. Densified DAE particles showed a slower dissolution rate than discrete DAE particles. because of their weak wettability and their poor disintegrant properties due to the particulate rearrangement under pressure. Lastly in a technological point of view, DAE could be considered as a potential drug delivery system in capsules or tablets to better control bioavailability of drugs. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:169 / 178
页数:10
相关论文
共 24 条
[11]  
FARAH N, 1986, Patent No. 8602694
[12]   THE EFFECT OF PARTICLE-SIZE DISTRIBUTION ON DISSOLUTION RATE AND ORAL ABSORPTION [J].
HINTZ, RJ ;
JOHNSON, KC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 51 (01) :9-17
[13]   Effect of physicochemical factors on the release kinetics of hydrophilic drugs from poly(L-lactic acid) (L-PLA) pellets [J].
Kader, A ;
Jalil, R .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1998, 24 (06) :535-539
[14]   In vitro release of theophylline from poly(lactic acid) sustained-release pellets prepared by direct compression [J].
Kader, A ;
Jalil, R .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1998, 24 (06) :527-534
[15]  
KNOP K, 1997, STP PHARMA SCI, V6, P507
[16]  
Luner PE, 2000, J PHARM SCI, V89, P382, DOI 10.1002/(SICI)1520-6017(200003)89:3<382::AID-JPS9>3.0.CO
[17]  
2-H
[18]  
Meshali MM, 1996, STP PHARMA SCI, V6, P370
[19]   DRUG RELEASE MECHANISM FROM A MICROCRYSTALLINE CELLULOSE PELLET SYSTEM [J].
OCONNOR, RE ;
SCHWARTZ, JB .
PHARMACEUTICAL RESEARCH, 1993, 10 (03) :356-361
[20]   Solid state characterisation of a dry emulsion:: a potential drug delivery system [J].
Pedersen, GP ;
Fäldt, P ;
Bergenståhl, B ;
Kristensen, HG .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 171 (02) :257-270